医学
心脏毒性
乳腺癌
化疗
内科学
肿瘤科
癌症
血管紧张素转换酶
血压
出处
期刊:JAMA
[American Medical Association]
日期:2019-07-23
卷期号:322 (4): 296-296
标识
DOI:10.1001/jama.2019.9782
摘要
An angiotensin-converting enzyme (ACE) inhibitor and β-blocker prevented cardiotoxicity associated with combination chemotherapy in women with ERBB2 (formerly HER2)–positive breast cancer, reported a trial in the Journal of the American College of Cardiology.
科研通智能强力驱动
Strongly Powered by AbleSci AI